Original Research
Accepted on 21 Apr 2025
Safety and tolerability of the treatment with a bevacizumab biosimilar (Effivia ® ) in adult Mexican patients with cancer: a multicenter, observational, prospective clinical study
in Anti-Cancer Drugs
Original Research
Accepted on 21 Apr 2025
in Anti-Cancer Drugs
Original Research
Published on 15 Apr 2025
in In silico Methods and Artificial Intelligence for Drug Discovery
Original Research
Published on 21 Feb 2025
in Neurological Drugs
Editorial
Published on 20 Feb 2025
in Technologies and Strategies to Enable Drug Discovery
Perspective
Published on 19 Feb 2025
in Technologies and Strategies to Enable Drug Discovery
Review
Published on 29 Jan 2025
in Anti-Cancer Drugs
Original Research
Published on 03 Jan 2025
in Technologies and Strategies to Enable Drug Discovery
Review
Published on 19 Dec 2024
in Anti-Cancer Drugs
Editorial
Published on 29 Nov 2024
in Technologies and Strategies to Enable Drug Discovery
Review
Published on 19 Nov 2024
in Technologies and Strategies to Enable Drug Discovery
Original Research
Published on 29 Oct 2024
in In silico Methods and Artificial Intelligence for Drug Discovery
Review
Published on 22 Oct 2024
in Technologies and Strategies to Enable Drug Discovery
Review
Published on 18 Oct 2024
in Technologies and Strategies to Enable Drug Discovery
Review
Published on 16 Oct 2024
in Anti-Infective Agents
Brief Research Report
Published on 07 Oct 2024
in Technologies and Strategies to Enable Drug Discovery
Original Research
Published on 02 Oct 2024
in Technologies and Strategies to Enable Drug Discovery